| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | $237.00K | $596.00K | $1.39M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $252.47M | $250.73M | $194.18M | $139.15M | $115.39M |
| R&D | $71.43M | $103.74M | $125.05M | $95.52M | $85.73M |
| SG&A | $159.26M | $145.73M | $69.14M | $43.63M | $29.66M |
| Operating Income | -$68.58M | -$173.73M | -$193.94M | -$138.55M | -$114.00M |
| Interest Expense | – | $18.50M | $8.31M | $6.88M | $3.74M |
| Tax Expense | $75.00K | $449.00K | $22.00K | – | – |
| Net Income | -$83.50M | -$174.57M | -$184.13M | -$141.90M | -$116.11M |
| EPS (basic) | -0.1300 | -0.2700 | -0.3200 | -0.3700 | -0.3500 |
| EPS (diluted) | -0.1300 | -0.2700 | -0.3200 | -0.3700 | -0.3500 |
| Shares (diluted) | $666.66M | $646.03M | $570.65M | $380.78M | $327.63M |